Chinese Pharmaceutical Market Forecast 2017-2027
LONDON, September 28, 2017 /PRNewswire/ --
Cardiovascular Diseases, Oncology, Respiratory Diseases, Infectious Diseases, Diabetes, CNS, Autoimmune Diseases, Hypertension, Dyslipidaemia, COPD, Asthma, Antidepressants, Small Molecules, Branded Drugs, Traditional Chinese Medicine, Biologics, Vaccines, Biosimilars, Generic Prescription Drugs, Over-the-Counter Drugs, Patented Prescription Drugs, Hospitals, Retail Pharmacies, Grassroots Clinics
The Chinese Pharmaceutical market [https://www.visiongain.com/Report/1998/Chinese-Pharmaceutical-Market-Forecast-2017-2027 ] is expected to grow at a CAGR of 12.3% in the second half of the forecast period. The Chinese Pharmaceutical market [https://www.visiongain.com/Report/1998/Chinese-Pharmaceutical-Market-Forecast-2017-2027 ] reached $145.4bn in 2016, dominated by the Cardiovascular therapy area which held 13.6% share of the market.
(Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 253-page report you will receive 68 tables and 90 figures- all unavailable elsewhere.
The 253-page report provides clear detailed insight into the Chinese Pharmaceutical market [https://www.visiongain.com/Report/1998/Chinese-Pharmaceutical-Market-Forecast-2017-2027 ] . Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
- Chinese Pharmaceutical market forecasts [https://www.visiongain.com/Report/1998/Chinese-Pharmaceutical-Market-Forecast-2017-2027 ] from 2017-2027
- This report also breaks down the revenue forecast for the Chinese Pharmaceutical market by therapy area: - Cardiovascular: including specific revenue forecasts for Hypertension and Dyslipidaemia - Anticancer - Infectious Diseases - Diabetes - Respiratory: including specific revenue forecasts for Asthma and COPD - Central Nervous System: including specific revenue forecasts for Antidepressants - Autoimmune - Others
This report lists and discusses the domestic pharmaceutical companies that dominate each submarket. Moreover, this report discusses the drivers and restraints of each submarket.
- This report also breaks down the revenue forecast for the Chinese Pharmaceutical market by leading product class: - Small Molecules: further broken down into Generics Drugs and Branded Drugs - Traditional Chinese Medicine - Biologics: further broken down into Biologics (branded), Vaccines and Biosimilars
This report lists and discusses the domestic pharmaceutical companies that dominate each submarket. Moreover, this report discusses the drivers and restraints of each submarket.
- This report also breaks down the revenue forecast for the Chinese Pharmaceutical market by leading type of drug: - Generic Prescription Drugs - Over-the-Counter (OTC) Drugs - Patented Prescription Drugs
This report lists and discusses the domestic pharmaceutical companies that dominate each submarket.
- This report also breaks down the revenue forecast for the Chinese Pharmaceutical market by sales channel: - Hospitals - Retail Pharmacies - Grassroots Clinics
This report lists and discusses the domestic pharmaceutical companies that dominate each submarket.
- This report discusses trends in the industry and assesses strengths and weaknesses, as well as opportunities and threats (SWOT) that influence the Chinese Pharmaceutical Market. It also analyses social, technological, economic and political factors (STEP) that influence the Chinese Pharmaceutical Market
- Our study ranks and provides 2016 revenues as well as market share of the top 50 domestic Chinese Pharmaceutical companies and top 10 Multinational Pharmaceutical Companies that are the major players in the Chinese Pharmaceutical Market
- Our study lists and discusses the leading domestic and multinational Contract Research Organizations (CRO) that dominate the Chinese Pharmaceutical Market.
Visiongain [https://www.visiongain.com ]'s study is intended for anyone requiring commercial analyses for the Chinese Pharmaceutical market [https://www.visiongain.com/Report/1998/Chinese-Pharmaceutical-Market-Forecast-2017-2027 ] . You find data, trends and predictions.
Buy our report today Chinese Pharmaceutical Market Forecast 2017-2027: Cardiovascular Diseases, Oncology, Respiratory Diseases, Infectious Diseases, Diabetes, CNS, Autoimmune Diseases, Hypertension, Dyslipidaemia, COPD, Asthma, Antidepressants, Small Molecules, Branded Drugs, Traditional Chinese Medicine, Biologics, Vaccines, Biosimilars, Generic Prescription Drugs, Over-the-Counter (OTC) Drugs, Patented Prescription Drugs, Hospitals, Retail Pharmacies, Grassroots Clinics, Domestic Pharmaceutical Companies, Multinational Pharmaceutical Companies.
To request a report overview of this report please email Sara Peerun at sara.peerun@visiongain.com or call Tel: +44-(0)-20-7336-6100.
Or click on https://www.visiongain.com/Report/1998/Chinese-Pharmaceutical-Market-Forecast-2017-2027
List of Companies Mentioned in the Report
3SBio
Acambis
Agilent
Alibaba Group
Alliance Boots
Amerisource-Bergen
Amgen
Anhui Anke Biotech
AppTech Laboratory Services
Asian Cancer Research Group
Astellas
AstraZeneca
Asymchem Laboratories
AXM Pharma
Baxter
Bayer
Bayer Healthcare
BeiGene
Beijing Four Rings Bio-pharmaceutical
Beijing Genomics Institute
Beijing Kexing Bioproducts
Beijing Key Yuan Xinhai Pharmaceutical
Beijing SL Pharmaceutical
Beijing Taiyang
Beijing Tiantan Biological Products
Beijing Tong Ren Tang
Bio-Bridge Science
BiODura
Bloomberg
Boehringer Ingelheim
Bristol-Myers Squibb
Buchang Pharma
Cardinal Health
CASiGEN Pharma
Celgene
Celsion Corp
Changzhou Qianhong Biopharma
Chemizon (Beijing) Pharma-Tech
Chengdu Di'ao Pharmaceutical Group
Chengdu Institutes of Biological Products
Chiesi Edding Hong Kong Limited
Chi-Med
China Chemical & Pharmaceutical Group
China National Accord
China National Biotec Group
China National Pharmaceutical Group
China NT Pharma Group
China Pharmaceutical Commerce Association
China Pharmaceutical Quality Management Association
China Resources Double-Crane Pharmaceuticals
China Resources Sanjiu Medical
China Shineway Pharmaceutical
China Traditional Chinese Medicine Co.
ChinaBio Group
ChinaGate
Chonqqing Taiji Industry
Cipla
Consun Pharmaceutical Group
Cord Blood America
Covance
CSPC Pharmaceutical Group
Daan Gene
Daiichi Sankyo
Dalian Hissen Bio-Pharm
Dawnrays Pharmaceutical Holdings
Dihon Pharmaceutical Group
Dongsheng Pharmaceutical
Dr. Reddy's Laboratories
Egret
Eisai
Eli Lilly
Excel PharmaStudies
FeRx Incorporated
Financial Times
Foshan City
Furen Pharmaceutical Group
Gan & Lee Pharmaceutical
Genentech
GeneScience Pharmaceuticals
Gilead Sciences
GlaxoSmithKline
Goldman Sachs
Guangdong BeiKang Pharmaceutical
Guangdong Techpool
Guangxi Wuzhou Zhongheng Group
Guangzhou Medical University
Guangzhou Pharma
Guangzhou Pharmaceutical Corporation
Guizhou Baiqiang Pharmaceutical
Hangzhou East China Pharmaceutical Group
Hangzhou Jiuyuan Gene Engineering
Hangzhou Tigermed Consulting
Hangzhou Zhongmei Huadong Pharmaceutical
Harbin Pharmaceutical Group
Harbin Tri-Lion Pharmaceutical
Harvard University
HD Biosciences
Henan Lingrui Pharmaceutical
Hengrui
Henlius Biopharmaceuticals
HitGen
Hua Medicine
Huadong Medicine
Hualan Biological Engineering
Hualida Biotech
Hutchinson Whampoa
Hutchison MediPharma
i3 Research
ICON
Inner Mongolia Yili Energy
Innovent Biologics
JD.com (Jindong Mall)
JHL Biotech
Jiangsu Chia-tai Tianqing Pharmaceutical
Jiangsu Hansen Pharmaceutical
Jiangsu Hansoh Pharmaceutical
Jiangsu Hengrui Medicine
Jiangsu Nhwa Pharmaceutical
Jilin Extrawell Changbaishan
Jilin Province Huinan Changlong
Jinling Pharmaceutical
Johnson & Johnson
Joincare Pharma
JOINN Laboratories
Kangmei Pharmaceutical
KPC Pharmaceuticals
Lepu Medical
Livzon Pharmaceutical Group
Lundbeck
Lundbeck Institute
Massachusetts Institute of Technology
McKesson
Merck & Co.
Merck Sharp & Dohme
Microport Medical
Mycenax
Mylan
Nanjing Kanghai Pharmaceutical
Nanjing Pharmaceutical Factory
Nestle Health Sciences
Nestle SA
Newsummit Biopharma
North China Pharmaceutical Group
Northeast Pharmaceutical Group (NEPG)
Novartis
Novast Laboratories
Novo Nordisk
Oncobiologics
Otsuka
Pfizer
Pharmaceutical Product Development LLC
Pharmaron
PKU Healthcare Group
Qilu Pharmaceutical
Quintiles
Roche
Sanofi
Schering-Plough
Servier
Shandong Dong-E E-Jiao
Shandong Kexing Bioproducts
Shanghai Celgen Bio-Pharmaceutical
Shanghai Charity Foundation
Shanghai CP Guojian Pharmaceuticals
Shanghai DND Pharm-Technology
Shanghai Fosun Pharmaceutical Group
Shanghai Furen Industrial
Shanghai Institutes of Biological Sciences
Shanghai Jinhe Bio-Technology
Shanghai Pharmaceuticals Holding
ShangPharma
Shenzhen Heapalink
Shenzhen Kangtai Biological Products
Shenzhen Neptunus Bioengineering
Shenzhen Salubris Pharmaceuticals
Shenzhen Wenle ('Main Luck') Pharmaceutical
Shijiazhuang Pharmaceutical Group
Shijiazhuang Yiling
Shineway Pharmaceutical Group
Sichuan Jiufeng Pharmaceutical
Sichuan Kelun Pharmaceutical
Sichuan Kelun Pharmaceutical
Sichuan Yuanda Shuyang Pharmaceutical
Sihuan Pharmaceutical Holdings
Simcere Pharmaceutical
SiniWest Holdings
Sino Biological
Sino Biopharmaceutical
Sinopharm
State Key Lab of Respiratory Disease
Sundia MediTech
Sundiro Pharma
Swiss Re
Symbio Pharmaceuticals
Takeda
Tangshan Yian Bioengineering
Tasly Pharmaceuticals
Teva
The Financial Times
Thermo Fisher Scientific
Tianjin Jin Yao Group
Tianjin Kinnovata Pharmaceutical Company
Tonghua Dongbao
United Pharmatech
Vectura
Venturepharm Laboratories
Vertex Pharmaceuticals
Viva Biotech
Wai Yuen Tong Medicine Holdings
Walmart Holdings
Wanbang Biopharmaceuticals
Weigao Holding
Winteam Pharmaceutical Group
WuXi AppTec
Xiamen Amoytop Biotech
Xian-Janssen Pharmaceuticals
Xiuzheng Pharmaceutical
Xizang Haisco
Yabao Pharmaceutical Group
Yangtze River Pharmaceuticals
Youcare Pharmaceutical Group
Yunnan Baiyao
Zai Lab
Zendex Bio Strategy
Zensun (Shanghai) Sci & Tech
Zhejiang Beta Pharma
Zhejiang Hisun Pharmaceutical
Zhejiang Huahai Pharmaceutical
Zhejiang Medicine
Zhejiang Tianyuan
Zhenjian Hisun Pharmaceuticals
Zhuhai United States Labs
Zuellig Pharma China
To see a report overview please email Sara Peerun on sara.peerun@visiongain.com
Photo:
http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg
SOURCE Visiongain Ltd
